Cargando…

From disease modelling to personalised therapy in patients with CEP290 mutations

Mutations that give rise to premature termination codons are a common cause of inherited genetic diseases. When transcripts containing these changes are generated, they are usually rapidly removed by the cell through the process of nonsense-mediated decay. Here we discuss observed changes in transcr...

Descripción completa

Detalles Bibliográficos
Autores principales: Molinari, Elisa, Srivastava, Shalabh, Sayer, John A., Ramsbottom, Simon A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482330/
https://www.ncbi.nlm.nih.gov/pubmed/28690834
http://dx.doi.org/10.12688/f1000research.11553.1
_version_ 1783245554542706688
author Molinari, Elisa
Srivastava, Shalabh
Sayer, John A.
Ramsbottom, Simon A.
author_facet Molinari, Elisa
Srivastava, Shalabh
Sayer, John A.
Ramsbottom, Simon A.
author_sort Molinari, Elisa
collection PubMed
description Mutations that give rise to premature termination codons are a common cause of inherited genetic diseases. When transcripts containing these changes are generated, they are usually rapidly removed by the cell through the process of nonsense-mediated decay. Here we discuss observed changes in transcripts of the centrosomal protein CEP290 resulting not from degradation, but from changes in exon usage. We also comment on a landmark paper (Drivas et al. Sci Transl Med. 2015) where modelling this process of exon usage may be used to predict disease severity in CEP290 ciliopathies, and how understanding this process may potentially be used for therapeutic benefit in the future.
format Online
Article
Text
id pubmed-5482330
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-54823302017-07-06 From disease modelling to personalised therapy in patients with CEP290 mutations Molinari, Elisa Srivastava, Shalabh Sayer, John A. Ramsbottom, Simon A. F1000Res Correspondence Mutations that give rise to premature termination codons are a common cause of inherited genetic diseases. When transcripts containing these changes are generated, they are usually rapidly removed by the cell through the process of nonsense-mediated decay. Here we discuss observed changes in transcripts of the centrosomal protein CEP290 resulting not from degradation, but from changes in exon usage. We also comment on a landmark paper (Drivas et al. Sci Transl Med. 2015) where modelling this process of exon usage may be used to predict disease severity in CEP290 ciliopathies, and how understanding this process may potentially be used for therapeutic benefit in the future. F1000Research 2017-05-12 /pmc/articles/PMC5482330/ /pubmed/28690834 http://dx.doi.org/10.12688/f1000research.11553.1 Text en Copyright: © 2017 Molinari E et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Molinari, Elisa
Srivastava, Shalabh
Sayer, John A.
Ramsbottom, Simon A.
From disease modelling to personalised therapy in patients with CEP290 mutations
title From disease modelling to personalised therapy in patients with CEP290 mutations
title_full From disease modelling to personalised therapy in patients with CEP290 mutations
title_fullStr From disease modelling to personalised therapy in patients with CEP290 mutations
title_full_unstemmed From disease modelling to personalised therapy in patients with CEP290 mutations
title_short From disease modelling to personalised therapy in patients with CEP290 mutations
title_sort from disease modelling to personalised therapy in patients with cep290 mutations
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482330/
https://www.ncbi.nlm.nih.gov/pubmed/28690834
http://dx.doi.org/10.12688/f1000research.11553.1
work_keys_str_mv AT molinarielisa fromdiseasemodellingtopersonalisedtherapyinpatientswithcep290mutations
AT srivastavashalabh fromdiseasemodellingtopersonalisedtherapyinpatientswithcep290mutations
AT sayerjohna fromdiseasemodellingtopersonalisedtherapyinpatientswithcep290mutations
AT ramsbottomsimona fromdiseasemodellingtopersonalisedtherapyinpatientswithcep290mutations